Dr. David Samadi - Prostate Cancer Drugs and Breast Cancer Screening Guidelines - Good Day NY

Dr. David Samadi, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital in NYC, discusses a new study suggesting that women be screened for breast cancer at the age of 40. The study showed that by starting screening at 40, rather than 50 as some guidelines suggest, a 30% reduction in breast cancer related death was found. He also discusses new prostate cancer "vaccines" that have been made available to those men who have late-stage, incurable prostate cancer that has spread to other organs in the body. These drugs, which cost around $90,000, extend a patient's life by an average of 2 months. Dr. Samadi believes that with time, and through competition between drug manufacturers, that these prices will eventually be reduced. Dr. David Samadi is the Chairman of Urology & Robotics Surgery at Lenox Hill Hospital. He's also a Fox News Medical-A-Team Contributor & Professor of Urology at Hofstra Northshore LIJ School of Medicine. Dr. David Samadi Prostate Cancer Center is situated at 485 Madison Avenue, 21st Floor, New York, NY 10022 | Phone: +1-212-365-5000 (https://goo.gl/maps/mfansYfCMAn) Connect with Dr. David Samadi: Web: http://www.prostatecancer911.com/ Facebook:   / drdavidsamadi   Twitter:   / drdavidsamadi   LinkedIn:   / davidsamadi   Instagram:   / drdavidsamadi   #DrDavidSamadi @DrDavidSamadi